Predicting EGFR mutation subtypes in lung adenocarcinoma using 18F-FDG PET/CT radiomic features
- PMID: 32676319
- PMCID: PMC7354146
- DOI: 10.21037/tlcr.2020.04.17
Predicting EGFR mutation subtypes in lung adenocarcinoma using 18F-FDG PET/CT radiomic features
Abstract
Background: Identification of epidermal growth factor receptor (EGFR) mutation types is crucial before tyrosine kinase inhibitors (TKIs) treatment. Radiomics is a new strategy to noninvasively predict the genetic status of cancer. In this study, we aimed to develop a predictive model based on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) radiomic features to identify the specific EGFR mutation subtypes.
Methods: We retrospectively studied 18F-FDG PET/CT images of 148 patients with isolated lung lesions, which were scanned in two hospitals with different CT scan setting (slice thickness: 3 and 5 mm, respectively). The tumor regions were manually segmented on PET/CT images, and 1,570 radiomic features (1,470 from CT and 100 from PET) were extracted from the tumor regions. Seven hundred and ninety-four radiomic features insensitive to different CT settings were first selected using the Mann white U test, and collinear features were further removed from them by recursively calculating the variation inflation factor. Then, multiple supervised machine learning models were applied to identify prognostic radiomic features through: (I) a multi-variate random forest to select features of high importance in discriminating different EGFR mutation status; (II) a logistic regression model to select features of the highest predictive value of the EGFR subtypes. The EGFR mutation predicting model was constructed from prognostic radiomic features using the popular Xgboost machine-learning algorithm and validated using 3-fold cross-validation. The performance of predicting model was analyzed using the receiver operating characteristic curve (ROC) and measured with the area under the curve (AUC).
Results: Two sets of prognostic radiomic features were found for specific EGFR mutation subtypes: 5 radiomic features for EGFR exon 19 deletions, and 5 radiomic features for EGFR exon 21 L858R missense. The corresponding radiomic predictors achieved the prediction accuracies of 0.77 and 0.92 in terms of AUC, respectively. Combing these two predictors, the overall model for predicting EGFR mutation positivity was also constructed, and the AUC was 0.87.
Conclusions: In our study, we established predictive models based on radiomic analysis of 18F-FDG PET/CT images. And it achieved a satisfying prediction power in the identification of EGFR mutation status as well as the certain EGFR mutation subtypes in lung cancer.
Keywords: 18F-FDG PET/CT; EGFR mutation subtypes; Lung adenocarcinoma; prediction; radiomic features.
2020 Translational Lung Cancer Research. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tlcr.2020.04.17). The authors have no conflicts of interest to declare.
Figures








Similar articles
-
Value of multi-center 18F-FDG PET/CT radiomics in predicting EGFR mutation status in lung adenocarcinoma.Med Phys. 2024 Jul;51(7):4872-4887. doi: 10.1002/mp.16947. Epub 2024 Jan 29. Med Phys. 2024. PMID: 38285641
-
Value of pre-therapy 18F-FDG PET/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer.Eur J Nucl Med Mol Imaging. 2020 May;47(5):1137-1146. doi: 10.1007/s00259-019-04592-1. Epub 2019 Nov 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31728587
-
Prediction of EGFR mutation status in lung adenocarcinoma based on 18F-FDG PET/CT radiomic features.Am J Nucl Med Mol Imaging. 2023 Oct 20;13(5):230-244. eCollection 2023. Am J Nucl Med Mol Imaging. 2023. PMID: 38023818 Free PMC article.
-
Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.Br J Radiol. 2021 Jun 1;94(1122):20201272. doi: 10.1259/bjr.20201272. Epub 2021 May 12. Br J Radiol. 2021. PMID: 33882244 Free PMC article.
-
Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer.Cancer Biomark. 2022;33(2):249-259. doi: 10.3233/CBM-210201. Cancer Biomark. 2022. PMID: 35213357 Review.
Cited by
-
The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges.Front Oncol. 2023 Mar 7;13:1133164. doi: 10.3389/fonc.2023.1133164. eCollection 2023. Front Oncol. 2023. PMID: 36959810 Free PMC article. Review.
-
18F-FDG PET/CT radiomic analysis for classifying and predicting microvascular invasion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Quant Imaging Med Surg. 2022 Aug;12(8):4135-4150. doi: 10.21037/qims-21-1167. Quant Imaging Med Surg. 2022. PMID: 35919043 Free PMC article.
-
Prognostic Significance of Regional/Systemic Metabolic Parameters on 18F-FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma.Front Oncol. 2021 Jun 17;11:675961. doi: 10.3389/fonc.2021.675961. eCollection 2021. Front Oncol. 2021. PMID: 34221995 Free PMC article.
-
A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.Eur Radiol Exp. 2024 Jan 2;8(1):2. doi: 10.1186/s41747-023-00396-z. Eur Radiol Exp. 2024. PMID: 38169047 Free PMC article.
-
Association Analysis of Maximum Standardized Uptake Values Based on 18F-FDG PET/CT and EGFR Mutation Status in Lung Adenocarcinoma.J Pers Med. 2023 Feb 23;13(3):396. doi: 10.3390/jpm13030396. J Pers Med. 2023. PMID: 36983578 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous